Lifecore Biomedical, Inc.

NASDAQ:LFCR

6.38 (USD) • At close April 25, 2025
Bedrijfsnaam Lifecore Biomedical, Inc.
Symbool LFCR
Munteenheid USD
Prijs 6.38
Beurswaarde 236,221,414
Dividendpercentage 0%
52-weken bereik 3.68 - 7.99
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. James G. Hall
Website https://www.lifecore.com

An error occurred while fetching data.

Over Lifecore Biomedical, Inc.

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated

Vergelijkbare Aandelen

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)